DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 USDMF

1 API Suppliers
1 USDMF

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: In-1130, 868612-83-3, In 1130, In1130, Chembl492634, Kw4o83pq97

Molecular Formula

C₂₅H₂₀N₆O

Molecular Weight

420.5 g/mol

InChI Key

RYKSGWSKILPDDY-UHFFFAOYSA-N

FDA UNII

KW4O83PQ97

1 2D Structure

Benzamide, 3-5-6-Methyl-2-Pyridinyl-4-6-Quinoxalinyl-1H-Imidazol-2-Yl-Methyl

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

3-[[5-(6-methylpyridin-2-yl)-4-quinoxalin-6-yl-1H-imidazol-2-yl]methyl]benzamide

2.1.2 InChI

InChI=1S/C25H20N6O/c1-15-4-2-7-20(29-15)24-23(17-8-9-19-21(14-17)28-11-10-27-19)30-22(31-24)13-16-5-3-6-18(12-16)25(26)32/h2-12,14H,13H2,1H3,(H2,26,32)(H,30,31)

2.1.3 InChI Key

RYKSGWSKILPDDY-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC1=NC(=CC=C1)C2=C(N=C(N2)CC3=CC(=CC=C3)C(=O)N)C4=CC5=NC=CN=C5C=C4

2.2 Other Identifiers

2.2.1 UNII

KW4O83PQ97

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 3-((5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1h-imidazol-2-yl)methyl)benzamide

2. In 1130

3. In-1130

4. In1130

2.3.2 Depositor-Supplied Synonyms

1. In-1130

2. 868612-83-3

3. In 1130

4. In1130

5. Chembl492634

6. Kw4o83pq97

7. Benzamide, 3-((5-(6-methyl-2-pyridinyl)-4-(6-quinoxalinyl)-1h-imidazol-2-yl)methyl)-

8. 3-((5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1h-imidazol-2-yl) Methyl)benzamide

9. 3-((5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1h-imidazol-2-yl)methyl)benzamide

10. Unii-kw4o83pq97

11. Schembl139815

12. Schembl22170124

13. Bdbm50252542

14. Zinc13985930

15. Akos032962854

16. Ncgc00386726-01

17. Ncgc00386726-02

18. Hy-18758

19. Cs-0014265

20. E98928

21. Q27282469

22. 3-[[5-(6-methyl-2-pyridinyl)-4-(6-quinoxalinyl)-1h-imidazol-2-yl]methyl]benzamide

23. 3-[[5-(6-methylpyridin-2-yl)-4-quinoxalin-6-yl-1h-imidazol-2-yl]methyl]benzamide

24. 940003-47-4

2.4 Create Date

2006-10-26

3 Chemical and Physical Properties

Molecular Formula	C₂₅H₂₀N₆O
Molecular Weight	420.5 g/mol
XLogP3	2.9
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	5
Exact Mass	420.16985928 g/mol
Monoisotopic Mass	420.16985928 g/mol
Topological Polar Surface Area	110 Å²
Heavy Atom Count	32
Formal Charge	0
Complexity	646
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1